Analyst Ratings for AnaptysBio (ANAB)
ANAB Rating Summary
ANAB Price Target Summary
- Highest: $140.00 (Guggenheim)
- Lowest: $50.00 (Truist Securities)
- Average: $81.82
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$81.82 (+42.3%)
* Over Last 12-Mos
Rating Score: 6.5 / 10
Percentile Rank: 68%
Avg. $ Target:
$81.82 (+42.3%)
* Over Last 12-Mos
Rating Score: 6.5 / 10
Percentile Rank: 68%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/10/2026 | H.C. Wainwright | Joseph Pantginis | New Coverage | Buy (N/A) |
95.00 (N/A) |
51.63 (57.51) |
11.39% | Details |
| 1/7/2026 | UBS » Updated 5/13/2026 |
Michael Yee | New Coverage | Buy (N/A) |
76.00 (60.00) |
43.20 (57.51) |
33.13% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
